Subsequent virtual screening of lead-like databases identified hits – structurally distinct from cromolyn – that show promise as inhibitors of S100P’s tumor-promoting mechanisms and therefore potentially as chemotherapeutic agents for PDAC. The gene discussed is S100P; the disease is neoplasm.